CCNE2, an S phase cyclin is frequently overexpressed in breast cancer [105] with previous studies reported the overexpression of Cyclin E including CCNE2 in IBC, with correlation of poor prognosis in IBC patients [106]. Here, CCNE2 is linked to inflammatory breast carcinoma.